Safety First: Uncovering the Clinical Risks Inside Your Compound Screening Data On-Demand Webinar 安全第一:揭示化合物筛选数据中的临床风险 Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and…Certara2026 年 1 月 13 日
New Approach Methodologies (NAMs): By the numbers GuideInfographic New Approach Methodologies (NAMs): By the numbers We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…Certara2025 年 12 月 10 日
New Approach Methodologies: Redefining Animal Testing Alternatives PodcastPress Coverage New Approach Methodologies: Redefining Animal Testing Alternatives Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…Certara2025 年 12 月 10 日
A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs Guide A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…Certara2025 年 11 月 17 日
Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs Announcement Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…Certara2025 年 11 月 12 日
Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk Publication Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…Danielle Pillsbury2025 年 11 月 7 日
In silico Safety and Toxicology assessment: ToxStudio® On-Demand Webinar In silico Safety and Toxicology assessment: ToxStudio® Discover how Certara’s ToxStudio align with FDA’s roadmap to reduce animal testing and transform preclinical…Certara2025 年 10 月 30 日
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research Press Coverage Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…Danielle Pillsbury2025 年 9 月 10 日
AI-driven drug discovery picks up as FDA pushes to reduce animal testing Press Coverage AI-driven drug discovery picks up as FDA pushes to reduce animal testing AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…Certara2025 年 9 月 9 日
Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling On-Demand Webinar 无动物实验的洞察:利用人源化芯片与 PBPK 建模 Certara2025 年 7 月 29 日